Welcome
Join the ELEVATE 2022 virtual journey, where we will hear from an esteemed faculty exploring the efficacy
and effectiveness of CDK4/6 inhibitors in HR+/HER2- aBC through plenary sessions and a panel
discussion. Meet the Chair, Prof. Hope S. Rugo, who will be joined by Dr Gabrielle Rocque and Dr Maggie
Banys-Paluchowski during this 60-minute educational webinar focused on education, evidence and experience.
Explore the full agenda below.
Agenda
Time
Session Title
Presenter
7 July 2022
Latest advances of CDK4/6 inhibitors:
Confidence and impact on
clinical practices
clinical practices
Chair: Prof. Hope S. Rugo
5 minutes
Welcome and introduction
Prof. Hope S. Rugo
15 minutes
Treatment benefit of CDK4/6 inhibitors in HR+/HER2- aBC
in clinical trials and the real world
in clinical trials and the real world
Prof. Hope S. Rugo
10 minutes
The increasing role of RWE in complementing clinical trial results
and healthcare decisions
and healthcare decisions
Dr Gabrielle Rocque
10 minutes
Optimising management of HR+/HER2- aBC (clinical experience)
Dr Maggie Banys-Paluchowski
15 minutes
Panel discussion and Q&A
Dr Gabrielle Rocque
Dr Maggie Banys-Paluchowski
Facilitated by:
Prof. Hope S. Rugo
Dr Maggie Banys-Paluchowski
Facilitated by:
Prof. Hope S. Rugo
5 minutes
Close and summary
Prof. Hope S. Rugo
Live translations in English, French, German, Indonesian, Italian, Russian, Spanish and Vietnamese will be available for this meeting.
